CS-101 in Patients With β-thalassemia
NCT06328764
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
ENROLLING_BY_INVITATION
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Beta-Thalassemia
Interventions
GENETIC:
CS-101
Sponsor
CorrectSequence Therapeutics Co., Ltd
Collaborators
[object Object]